Immune checkpoint inhibitor induced colitis: A nationwide population-based study
Natalie Farha, Motasem Alkhayyat, Adrian Lindsey, Emad Mansoor, Mohannad Abou Saleh
Topics & Concepts
MedicineIpilimumabInternal medicineColitisOdds ratioNivolumabAtezolizumabPopulationCohortEpidemiologyUlcerative colitisGastroenterologyCancerDiseaseImmunotherapyEnvironmental healthCancer Immunotherapy and BiomarkersInflammatory Biomarkers in Disease PrognosisTryptophan and brain disorders